Suscribirse

Curcumin may reverse 5-fluorouracil resistance on colonic cancer cells by regulating TET1-NKD-Wnt signal pathway to inhibit the EMT progress - 28/08/20

Doi : 10.1016/j.biopha.2020.110381 
Yi Lu e, 1 , Runzhe Zhang d, 1, Xinjie Zhang d, Bo Zhang a, b, c, Qinghua Yao a, b, c,
a Department of Integrated Chinese and Western Medicine, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) 
b Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences 
c Key laboratory of Integrated Traditional Chinese and Western Medicine, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), No. 1 Banshandong Road, Gongshu District, Hangzhou, Zhejiang Province 
d Second Clinical College of Zhejiang Chinese Medical University, No.548 Binwen Road, Binjiang District, Hangzhou, Zhejiang Province 
e Department of Nutrition, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

páginas 9
Iconografías 6
Vídeos 0
Otros 0

Graphical abstract

Curcumin up-regulated the expression of TET1, which could also be promoted by its transcriptional mediator Pax-6 and in turns induced the expression of NKD2. The WNT signal pathway was inhibited by the high expressed NKD2 and EMT progress was suppressed. As a result, the migration and invasion of 5-FU resistance HCT-116 cells were inhibited. The present study claimed a possible signal pathway mechanism explaining the anti-resistant effects of curcumin against 5-FU resistance HCT-116 cells.




El texto completo de este artículo está disponible en PDF.

Highlights

Curcumin enhanced the inhibitory effects of 5-FU against the cell growth of 5-FU resistant HCT-116 cells.
WNT signal pathway in resistant HCT-116 cells was significantly inhibited by curcumin.
We supposed that curcumin and Pax-6 might exert the same function on TET1.

El texto completo de este artículo está disponible en PDF.

Abstract

Background and purpose

Colorectal cancer is a kind of gastrointestinal tumor with rising morbidity and mortality. 5-fluorouracil is one of the most effective chemotherapy drugs for the treatment of CRC. However, clinical data reported dramatic resistance on the treatment for CRC with 5-fluorouracil. Present study aims to explore the anti-resistant effect of curcumin and its mechanism.

Methods

MTT assay was used to evaluate the proliferation of rHCT-116 cells. Flow cytometry was used to determine the apoptosis and cell cycle of rHCT-116 cells. Western Blot was performed to detect the expression level of TET1, NKD2, E-cadherin, Vimentin, β-catenin, TCF4 and Axin in transfected rHCT-116 cells.

Results

5-fluorouracil resistant HCT-116 cells were successfully established. Curcumin was found to be effective in the inhibition of proliferation, inducement of apoptosis and block of G0/G1 phase on 5-fluorouracil treated HCT-116 cells. The expression of TET1 and NKD2 was greatly inhibited by high dosage of curcumin. The WNT signal pathway and EMT progress were suppressed in rHCT-116 cells by high dosage of curcumin. The inhibitory effects of curcumin on WNT signal pathway and EMT progress were verified to be consistent with Pax-6, TET1 and NKD2.

Conclusion

Curcumin might exert anti-resistant effect of 5-FU on HCT-116 cells by regulating the TET1-NKD2-WNT signal pathway to inhibit the EMT progress.

El texto completo de este artículo está disponible en PDF.

Keywords : Curcumin, Colonic cancer, EMT, Wnt, 5-fluorouracil


Esquema


© 2020  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 129

Artículo 110381- septembre 2020 Regresar al número
Artículo precedente Artículo precedente
  • Molecular docking-based virtual drug screening revealing an oxofluorenyl benzamide and a bromonaphthalene sulfonamido hydroxybenzoic acid as HDAC6 inhibitors with cytotoxicity against leukemia cells
  • Mona Dawood, Mohamed Elbadawi, Madeleine Böckers, Gerhard Bringmann, Thomas Efferth
| Artículo siguiente Artículo siguiente
  • Anti-ischemia/reperfusion injury effects of notoginsenoside R1 on small molecule metabolism in rat brain after ischemic stroke as visualized by MALDI–MS imaging
  • Ting Zhu, Lei Wang, Fang Tian, Xin Zhao, Xiao-Ping Pu, Gui-Bo Sun, Xiao-Bo Sun

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.